UBS Group’s Cartica Acquisition Corp Unit CITEU Stock Holding History

UBS Group’s Portfolio CITEU Stock Details CITEU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,483	Closed	-$15.3K	–	11571
2022 Q4	$15.3K	Hold	1,483	–	–	﹤0.01%	7993
2022 Q3	$15K	Hold	1,483	–	–	﹤0.01%	7886
2022 Q2	$15K	Hold	1,483	–	–	﹤0.01%	7372
2022 Q1	$15K	Buy	+1,483	New	+$14.9K	﹤0.01%	7909

Other funds holding CITEU

Cartica Management Washington, District of Columbia $20.9M AUM 14.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group's CITEU Position: Q1 2023 in Review

UBS Group sold out of Cartica Acquisition Corp Unit (CITEU) in Q1 2023, closing a stake of 1,483 shares — an estimated $15.3K sold.

UBS Group first reported a position in CITEU in Q1 2022 and held it in 4 quarters. The position peaked at $15.3K in Q4 2022. 8 funds tracked by Wall St. Rank hold CITEU as of Q1 2023.

UBS Group reported no remaining Cartica Acquisition Corp Unit position as of Q1 2023 after selling out during the quarter.
UBS Group sold 1,483 Cartica Acquisition Corp Unit shares in Q1 2023, an estimated $15.3K.
UBS Group first reported a position in Cartica Acquisition Corp Unit in Q1 2022 and held it in 4 quarters.
UBS Group's Cartica Acquisition Corp Unit position peaked at $15.3K in Q4 2022.
8 funds tracked by Wall St. Rank held Cartica Acquisition Corp Unit as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.